FI64801C - Foerfarande foer framstaellning av n-heterocyklyl-4-piperidinaminer med verkan av antihistamin - Google Patents
Foerfarande foer framstaellning av n-heterocyklyl-4-piperidinaminer med verkan av antihistamin Download PDFInfo
- Publication number
- FI64801C FI64801C FI791084A FI791084A FI64801C FI 64801 C FI64801 C FI 64801C FI 791084 A FI791084 A FI 791084A FI 791084 A FI791084 A FI 791084A FI 64801 C FI64801 C FI 64801C
- Authority
- FI
- Finland
- Prior art keywords
- group
- formula
- parts
- benzimidazol
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89253478A | 1978-04-03 | 1978-04-03 | |
US89253478 | 1978-04-03 | ||
US06/002,276 US4219559A (en) | 1979-01-10 | 1979-01-10 | N-Heterocyclyl-4-piperidinamines |
US227679 | 1979-01-10 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI791084A FI791084A (fi) | 1979-10-04 |
FI64801B FI64801B (fi) | 1983-09-30 |
FI64801C true FI64801C (fi) | 1984-01-10 |
Family
ID=26670178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI791084A FI64801C (fi) | 1978-04-03 | 1979-04-02 | Foerfarande foer framstaellning av n-heterocyklyl-4-piperidinaminer med verkan av antihistamin |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP0005318B1 (fr) |
JP (2) | JPS54151982A (fr) |
AT (1) | AT373887B (fr) |
AU (1) | AU523352B2 (fr) |
BG (1) | BG38164A3 (fr) |
CA (1) | CA1140119A (fr) |
CS (1) | CS256358B2 (fr) |
CY (1) | CY1250A (fr) |
DE (1) | DE2961740D1 (fr) |
DK (1) | DK169325B1 (fr) |
EG (1) | EG13913A (fr) |
ES (1) | ES479206A1 (fr) |
FI (1) | FI64801C (fr) |
GR (1) | GR64907B (fr) |
HK (1) | HK3184A (fr) |
HU (1) | HU182965B (fr) |
IE (1) | IE47818B1 (fr) |
IL (1) | IL56992A (fr) |
MY (1) | MY8500046A (fr) |
NO (2) | NO154058C (fr) |
NZ (1) | NZ189978A (fr) |
PH (1) | PH15877A (fr) |
PL (1) | PL123380B1 (fr) |
PT (1) | PT69429A (fr) |
RO (1) | RO79320A (fr) |
SG (1) | SG29883G (fr) |
SU (1) | SU1056902A3 (fr) |
YU (2) | YU42484B (fr) |
ZA (1) | ZA791557B (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA19091A1 (fr) * | 1980-03-10 | 1981-10-01 | Janssen Pharmaceutica Nv | Nouveaux derives de i-(4-aryl-cyclohexyl)piperidine . |
US4556660A (en) * | 1982-07-12 | 1985-12-03 | Janssen Pharmaceutica N.V. | N-(Bicyclic heterocyclyl)-4-piperidinamines |
IN156065B (fr) * | 1982-07-12 | 1985-05-04 | Janssen Pharmaceutica Nv | |
US4634704A (en) * | 1983-10-06 | 1987-01-06 | Janssen Pharmaceutica, N.V. | Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines |
DE3484096D1 (de) * | 1983-11-30 | 1991-03-14 | Janssen Pharmaceutica Nv | Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine. |
PL144514B1 (en) * | 1984-01-09 | 1988-06-30 | Janssen Pharmaceutica Nv | Method of obtaining novel derivatives of n-/4-piperidinolo/-2-imidazoloamine |
KR930005004B1 (ko) * | 1985-04-15 | 1993-06-11 | 쟈안센 파아마슈우티카 엔. 부이. | 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법 |
GB8515934D0 (en) * | 1985-06-24 | 1985-07-24 | Janssen Pharmaceutica Nv | (4-piperidinomethyl and-hetero)purines |
EG17993A (en) * | 1986-02-03 | 1991-08-30 | Janssen Pharmaceutica Nv | Anti-histaminic compositions containing n-heterocyclyl-4-piperidinanines |
NZ223654A (en) * | 1987-03-09 | 1990-03-27 | Janssen Pharmaceutica Nv | 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions |
FR2618435B1 (fr) * | 1987-07-23 | 1989-10-27 | Synthelabo | Derives de benzimidazole, leur preparation et leur application en therapeutique |
US5210091A (en) * | 1991-06-24 | 1993-05-11 | Neurosearch A/S | Imidazole compounds and their use |
CA2161876A1 (fr) * | 1993-05-20 | 1994-12-08 | Den-Ichi Momose | Composes de type 1-(2-benzimidazolyl)-1,5-diazacyclooctane |
US5547966A (en) * | 1993-10-07 | 1996-08-20 | Bristol-Myers Squibb Company | Aryl urea and related compounds |
KR20010032968A (ko) * | 1998-03-06 | 2001-04-25 | 디르크 반테 | 글리신 수송 저해제 |
BR0011997A (pt) | 1999-06-28 | 2002-03-05 | Janssen Pharmaceutica Nv | Inibidores da replicação do vìrus sincicial respiratório |
AU778218B2 (en) | 1999-06-28 | 2004-11-25 | Janssen Pharmaceutica N.V. | Respiratory syncytial virus replication inhibitors |
EE04590B1 (et) * | 1999-06-28 | 2006-02-15 | Janssen Pharmaceutica N.V. | Respiratoorse süntsütiaalviiruse replikatsiooni inhibiitorid, nende kasutamine ja valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod ning produkt |
RU2398765C1 (ru) | 2000-03-06 | 2010-09-10 | Акадиа Фармасьютикалз, Инк. | Азациклические соединения для применения при лечении опосредованных серотонином заболеваний |
CN1876647A (zh) | 2001-02-02 | 2006-12-13 | 特瓦制药工业有限公司 | 苯并咪唑化合物产品 |
NZ533567A (en) | 2001-12-28 | 2007-06-29 | Acadia Pharm Inc | Spiroazacyclic compounds as monoamine receptor for modulating 5-HT2A receptor-mediated events |
JP4625637B2 (ja) | 2002-02-22 | 2011-02-02 | シャイア エルエルシー | 活性物質送達系及び活性物質を保護し投与する方法 |
WO2004000808A2 (fr) | 2002-06-24 | 2003-12-31 | Acadia Pharmaceuticals Inc. | Derives de piperidine substitues en n en tant qu'agents recepteurs de la serotonine |
US7253186B2 (en) | 2002-06-24 | 2007-08-07 | Carl-Magnus Andersson | N-substituted piperidine derivatives as serotonin receptor agents |
US7538222B2 (en) | 2002-06-24 | 2009-05-26 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
ES2314362T3 (es) | 2003-01-16 | 2009-03-16 | Acadia Pharmaceuticals Inc. | Agonistas inversos selectivos de los receptores 2a o 2c de serotonina utilizados como agentes terapeuticos contra enfermedades neurodegenerativas. |
DK1697347T3 (da) | 2003-12-18 | 2011-06-06 | Tibotec Pharm Ltd | 5- eller 6-substituerede benzimidazolderivater som inhibitorer af replikation af respiratorisk syncytial-virus |
AR046971A1 (es) | 2003-12-18 | 2006-01-04 | Tibotec Pharm Ltd | Aminobenzoimidazoles y benzoimidazoles como inhibidores de la replicacion del virus sincitial respiratorio |
US7355051B2 (en) * | 2003-12-18 | 2008-04-08 | Tibotec Pharmaceuticals | Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
US7820695B2 (en) | 2004-05-21 | 2010-10-26 | Acadia Pharmaceuticals, Inc. | Selective serotonin receptor inverse agonists as therapeutics for disease |
US20050261278A1 (en) | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
US7790899B2 (en) | 2004-09-27 | 2010-09-07 | Acadia Pharmaceuticals, Inc. | Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
JP5154227B2 (ja) | 2004-09-27 | 2013-02-27 | アカディア ファーマシューティカルズ インコーポレイテッド | N−(4−フルオロベンジル)−n−(1−メチルピペリジン−4−イル)−n’−(4−(2−メチルプロピルオキシ)フェニルメチル)カルバミドの塩及びその調製 |
JP2010522198A (ja) | 2007-03-19 | 2010-07-01 | アカドイア プハルマセウチカルス インコーポレーテッド | 5−ht2aインバースアゴニスト及びアンタゴニストの抗精神病薬との併用 |
SI3325444T1 (sl) | 2015-07-20 | 2021-11-30 | Acadia Pharmaceuticals Inc. | Postopki za pripravo N-(4-fluorobenzil)-N-(1-metilpiperidin-4-il)-N'- (4-(2-metilpropiloksi)fenilmetil)karbamida in njegove tartratne soli in polimorfne oblike C |
US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
WO2017165635A1 (fr) | 2016-03-25 | 2017-09-28 | Acadia Pharmaceuticals Inc. | Association de pimavansérine et de modulateurs du cytochrome p450 |
EP3558311A1 (fr) | 2016-12-20 | 2019-10-30 | Acadia Pharmaceuticals Inc. | Pimavansérine seule ou en association pour une utilisation dans le traitement de la psychose liée à la maladie d'alzheimer |
WO2018200977A1 (fr) | 2017-04-28 | 2018-11-01 | Acadia Pharmaceuticals Inc. | Pimavansérine pour le traitement d'un trouble de contrôle des impulsions |
EP3675827A1 (fr) | 2017-08-30 | 2020-07-08 | Acadia Pharmaceuticals Inc. | Formulations de pimavansérine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2857391A (en) * | 1955-04-15 | 1958-10-21 | Merck & Co Inc | Aminomethylbenzimidazoles |
US2971005A (en) * | 1958-10-17 | 1961-02-07 | Merck & Co Inc | Nu-substituted derivatives of 2-benzylaminobenzimidazoles |
BE788065A (fr) * | 1971-08-26 | 1973-02-26 | Degussa | Nouvelles aza-benzimidazoles et procede pour leur preparation |
-
1979
- 1979-03-19 CA CA000323763A patent/CA1140119A/fr not_active Expired
- 1979-03-21 AU AU45296/79A patent/AU523352B2/en not_active Expired
- 1979-03-23 NZ NZ189978A patent/NZ189978A/en unknown
- 1979-03-29 GR GR58721A patent/GR64907B/el unknown
- 1979-03-29 DK DK129879A patent/DK169325B1/da not_active IP Right Cessation
- 1979-03-30 DE DE7979300525T patent/DE2961740D1/de not_active Expired
- 1979-03-30 EP EP79300525A patent/EP0005318B1/fr not_active Expired
- 1979-03-30 RO RO7997082A patent/RO79320A/fr unknown
- 1979-03-30 CY CY1250A patent/CY1250A/xx unknown
- 1979-04-01 EG EG200/79A patent/EG13913A/xx active
- 1979-04-02 ES ES479206A patent/ES479206A1/es not_active Expired
- 1979-04-02 ZA ZA791557A patent/ZA791557B/xx unknown
- 1979-04-02 NO NO791097A patent/NO154058C/no unknown
- 1979-04-02 AT AT0242579A patent/AT373887B/de not_active IP Right Cessation
- 1979-04-02 JP JP3844779A patent/JPS54151982A/ja active Granted
- 1979-04-02 IL IL56992A patent/IL56992A/xx unknown
- 1979-04-02 FI FI791084A patent/FI64801C/fi not_active IP Right Cessation
- 1979-04-02 CS CS792227A patent/CS256358B2/cs unknown
- 1979-04-03 BG BG7943114A patent/BG38164A3/xx unknown
- 1979-04-03 PL PL1979214648A patent/PL123380B1/pl unknown
- 1979-04-03 YU YU784/79A patent/YU42484B/xx unknown
- 1979-04-03 HU HU79JA841A patent/HU182965B/hu unknown
- 1979-04-03 PT PT69429A patent/PT69429A/pt unknown
- 1979-04-03 SU SU792747000A patent/SU1056902A3/ru active
- 1979-04-03 PH PH22344A patent/PH15877A/en unknown
- 1979-08-08 IE IE676/79A patent/IE47818B1/en not_active IP Right Cessation
-
1983
- 1983-03-02 YU YU502/83A patent/YU43158B/xx unknown
- 1983-05-26 SG SG298/83A patent/SG29883G/en unknown
-
1984
- 1984-01-12 HK HK31/84A patent/HK3184A/xx not_active IP Right Cessation
- 1984-06-25 NO NO842563A patent/NO154090C/no unknown
-
1985
- 1985-12-30 MY MY46/85A patent/MY8500046A/xx unknown
-
1988
- 1988-06-14 JP JP63144898A patent/JPH01117880A/ja active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI64801C (fi) | Foerfarande foer framstaellning av n-heterocyklyl-4-piperidinaminer med verkan av antihistamin | |
US4219559A (en) | N-Heterocyclyl-4-piperidinamines | |
FI81797C (fi) | Foerfarande foer framstaellning av en fem-ledad heterocyklisk ring innehaollande terapeutiskt aktiva n-(bicyklisk heterocyklyl)-4-piperidinaminer. | |
FI83781B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara bicykliska kondenserade n-(4-piperidinyl)-2 -imidazolaminderivat. | |
FI78480C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-(bicyklis heterocyklyl)-4-piperidinaminderivat. | |
FI82046C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara bensoxazol-, bensotiazol- och tiazolopyridinaminer. | |
FI93728B (fi) | Menetelmä terapeuttisesti käyttökelpoisten etoksietyyli-bentsimidatsoli- tai imidatsopyridiiniyhdisteiden valmistamiseksi | |
AU730369B2 (en) | Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists | |
EP1848696A1 (fr) | Derives d'imidazole et de benzimidazole utiles en tant qu'antagonistes de l'histamine h3 | |
CA2741661A1 (fr) | Nouveau derive amide et son utilisation comme medicament | |
Janssens et al. | New antihistaminic N-heterocyclic 4-piperidinamines. 2. Synthesis and antihistaminic activity of 1-[(4-fluorophenyl) methyl]-N-(4-piperidinyl)-1H-benzimidazol-2-amines | |
FI62667B (fi) | Foerfarande foer framstaellning av antiemetiska 1-(benzazolylalkyl)piperidinderivat | |
CA2600507C (fr) | 1,3-dihydrobenzimidazol-2-ylideneamines servant d'inhibiteurs de la replication du virus respiratoire syncytial | |
FI90233B (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten furanyylimetyylisubstituoitujen bentsimidatsoli- ja imidatsopyridiinijohdannaisten valmistamiseksi | |
CZ183699A3 (cs) | 2-Imidazolinylaminobenzoxazolové sloučeniny užitečné jako alfa-2 adrenoceptorové agonisty | |
JPH01228986A (ja) | [(5(6)(1h―アゾール―1―イルメチル)ベンズイミダゾール]カーバメート | |
RU2188822C2 (ru) | Производное бензимидазола и средство, обладающее антагонистической активностью против вещества р и антигистаминовой активностью | |
DK171841B1 (da) | N-hetero-cyclyl-4-piperidinaminer | |
JPH0413666A (ja) | 1―(アルコキシフェニル)―3―(4,5,6,7―テトラヒドロベンズイミダゾリル)ウレア | |
KR810001715B1 (ko) | 5-[4-(디아릴메틸)-1-피페라지닐알킬〕벤즈이미다졸 유도체의 제조방법 | |
Jha | Department of Chemistry, Acadia University, Wolfville, B4P 2R6, Nova Scotia, Canada E-mail: amitabh. jha@ acadiau. ca | |
FI84070B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara imidazopyridinylaminopiperidinderivat och mellanprodukter anvaendbara i foerfarandet. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired | ||
MA | Patent expired |
Owner name: JANSSEN PHARMACEUTICA N.V. |